VEGFA and breast neoplasm: Breast tumor-derived EVs express a 90 kDa crosslinked form of VEGF (VEGF90) on their membrane that leads to a sustained activation of VEGF receptors on endothelial cells, and stimulated their migration and tubulogenesis.